Abstract

We aimed to identify human papillomavirus (HPV) and HPV vaccine-related knowledge, attitudes, and beliefs among women aged 27-45years, who became eligible for HPV vaccination in2018. Eight virtual focus groups were conducted with 52 unvaccinated cisgender women aged 27-45years living in Southern California's Inland Empire. Themes related to women's knowledge, attitudes, and beliefs were systematically identified using the rigorous and accelerated data reduction technique. The sample was diverse: 62% of participants were Hispanic, Black, or Asian; 17% identified as lesbian or bisexual; and annual household incomes ranged from $0 to $260,000 (median, $60,500). Key qualitative themes centered on 1) questions about HPV and HPV vaccination, 2) knowledge and beliefs about HPV and HPV vaccination, 3) concerns about vaccine side effects and safety, 4) low perceived benefits of vaccination, and 5) social factors influencing vaccine acceptance. Few participants were aware adults aged 27-45years are eligible for HPV vaccination or that vaccination can still be beneficial after sexual debut. Many believed HPV vaccination caused serious side effects among adolescents and questioned whether safety had been adequately studied for newly eligible adults. Although many participants associated HPV vaccination with social stigma, some emphasized that vaccination was a way to exercise control over their health and prevent illness, given they could not always control the actions of their sexual contacts. Findings provide insight into knowledge, attitudes, and beliefs about HPV and HPV vaccination among women aged 27-45years, which may be useful for informing interventions to promote shared clinical decision-making between patients and health providers.

Highlights

  • We aimed to identify human papillomavirus (HPV) and HPV vaccine-related knowledge, attitudes, and beliefs among women aged 27–45 years, who became eligible for HPV vaccination in 2018

  • Forty-two participants had previously been eligible for HPV vaccination before age 27, among which 14 (33%) recalled a health provider ever recommending HPV vaccination to them

  • Mistaken beliefs and concerns about side effects and safety are established barriers to HPV vaccine uptake among younger populations (Zimet et al, 2013) and our findings suggest they remain salient for women over 26 years of age

Read more

Summary

Introduction

We aimed to identify human papillomavirus (HPV) and HPV vaccine-related knowledge, attitudes, and beliefs among women aged 27–45 years, who became eligible for HPV vaccination in 2018. Themes related to women’s knowledge, attitudes, and beliefs were systematically identified using the rigorous and accelerated data reduction technique. Few participants were aware adults aged 27–45 years are eligible for HPV vaccination or that vaccination can still be beneficial after sexual debut. Many believed HPV vaccination caused serious side effects among adolescents and questioned whether safety had been adequately studied for newly eligible adults. Conclusions: Findings provide insight into knowledge, attitudes, and beliefs about HPV and HPV vaccination among women aged 27–45 years, which may be useful for informing interventions to promote shared clinical decision-making between patients and health providers. The Advisory Committee on Immunization Practices (ACIP) recommends people in this age range engage in

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call